Prediction of Local Anaesthetic Dosing During Labour Epidural Analgesia (DIANA)
22 de mayo de 2026 actualizado por: ZANFINI BRUNO ANTONIO, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Prediction of Local Anaesthetic Dosing During Labour Epidural Analgesia: a Machine-learning Approach. The DIANA (Dosing Intrapartum ANAesthetics) Study.
Epidural analgesia is the gold standard for controlling labour pain. However, labour pain happens during neuraxial analgesia, due to anaesthetic, obstetric, maternal factors.
The investigators hypothesized that relevant variables, able to predict the local anaesthetic (LA) requirement during labour, can be identified at admission and each parturient may therefore be accordingly classified in "low-requirement" and "high-requirement". In this way, a predictive score may be developed, and the analgesic regimen may be matched to the individual patient, thus ensuring a timely and appropriate treatment of patients likely to require higher doses of LA, while minimizing potentially side effects of excessive treatment in the low-dose group.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Tipo de estudio
De observación
Inscripción (Estimado)
12500
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Bruno A Zanfini, MD
- Número de teléfono: 06 3015 3105
- Correo electrónico: brunoantonio.zanfini@policlinicogemelli.it
Ubicaciones de estudio
-
-
RM
-
Rome, RM, Italia, 00168
- Fondazione Policlinico Universitario A. Gemelli IRCCS
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Método de muestreo
Muestra no probabilística
Población de estudio
All parturients who delivered via vaginal route or intrapartum caesarean section and received neuraxial analgesia (epidural analgesia (EA) or combined spinal-epidural [CSE] analgesia or dural puncture epidural (DPE)) in Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, between January 1st, 2020 and March 01th, 2026 (including follow-up data), meeting the inclusion criteria.
Descripción
Inclusion Criteria:
- Parturients receiving neuraxial analgesia for labour, as clinical practice
Exclusion Criteria:
- Planned caesarean delivery
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
All parturients between January 2020 and March 2026
All parturients who delivered via vaginal route or intrapartum caesarean section and received neuraxial analgesia (epidural analgesia (EA) or combined spinal-epidural [CSE] analgesia or dural puncture epidural (DPE)) in Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, between January 1st, 2020 and March 01th, 2026 (including follow-up data), meeting the inclusion criteria.
Labour analgesia was maintained through manual top-up boluses or PIEB (Programmed Intermittent Epidural Bolus).
|
A machine-learning prediction model will be developed to anticipate the parturient's requirement of LA at admission in the Labour Suite, according to demographic, obstetric and anaesthetic features ongoing before administration of the first epidural bolus.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Machine-learning algorithm able to predict the LA consumption
Periodo de tiempo: From the epidural catheter placement to delivery.
|
To develop a machine-learning algorithm able to predict the mean hourly cumulative LA consumption administered via the epidural catheter from the catheter placement up to delivery, expressed as time-weighted LA consumption per hour (mg/h) in patients receiving top-up analgesia or the need for adjunctive rescue LA boluses in patients receiving PIEB (Programmed Intermittent Epidural Bolus) analgesia.
|
From the epidural catheter placement to delivery.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Clinical score
Periodo de tiempo: At admission in the Labour Suite and before the epidural catheter is placed
|
To develop a clinical score, based on the machine learning algorithm, with the aim of predicting the patient's LA requirement at admission, thus categorizing parturients as "low requirement" or "high requirement".
|
At admission in the Labour Suite and before the epidural catheter is placed
|
|
Time-dependent AUC of LA manual boluses
Periodo de tiempo: From epidural catheter placement to delivery.
|
To compare (between low- and high-requirement parturients) the time-dependent AUC of LA boluses (in case of analgesia maintenance through top-up) and the time-dependent AUC of adjunctive rescue LA boluses (in case of analgesia maintenance through PIEB)
|
From epidural catheter placement to delivery.
|
|
Total LA consumption
Periodo de tiempo: From epidural catheter placement to delivery.
|
To compare between low- and high-requirement parturients the total LA consumption (mg), mean (+-SD)
|
From epidural catheter placement to delivery.
|
|
Ratio of time to first bolus demand to duration of labor
Periodo de tiempo: From epidural catheter placement to delivery.
|
To compare between low- and high-requirement parturients the ratio of time to first bolus demand to duration of labor (%), mean (+-SD), in case of analgesia maintenance through top-up.
|
From epidural catheter placement to delivery.
|
|
Total demand of LA boluses
Periodo de tiempo: From epidural catheter placement to delivery.
|
To compare between low- and high-requirement parturients the total demand of LA boluses, mean (+-SD), in case of analgesia maintenance through top-up.
|
From epidural catheter placement to delivery.
|
|
Total adjunctive rescue LA epidural boluses
Periodo de tiempo: From epidural catheter placement to delivery.
|
To compare between low- and high-requirement parturients the total adjunctive rescue LA epidural boluses, mean (+-SD), in case of analgesia maintenance through PIEB.
|
From epidural catheter placement to delivery.
|
|
Length of active phase
Periodo de tiempo: From start of the active phase to full cervical dilation, up to 24 hours.
|
To compare between low- and high-requirement parturients the length of active phase in minutes, mean (+-SD).
|
From start of the active phase to full cervical dilation, up to 24 hours.
|
|
Length of second stage
Periodo de tiempo: From full cervical dilation to delivery.
|
To compare between low- and high-requirement parturients the length of second stage in minutes, mean (+-SD).
|
From full cervical dilation to delivery.
|
|
Rate of postpartum haemorrhage
Periodo de tiempo: In the first hour after delivery.
|
To compare between low- and high-requirement parturients the rate of postpartum haemorrhage, expressed as percentage.
|
In the first hour after delivery.
|
|
Rate of perineal laceration
Periodo de tiempo: In the first hour after delivery.
|
To compare between low- and high-requirement parturients the rate of perineal laceration, expressed as percentage.
|
In the first hour after delivery.
|
|
Rate of episiotomy
Periodo de tiempo: At delivery.
|
To compare between low- and high-requirement parturients the rate of episiotomy, expressed as percentage.
|
At delivery.
|
|
Rate of shoulder dystocia
Periodo de tiempo: At delivery.
|
To compare between low- and high-requirement parturients the rate of shoulder dystocia, expressed as percentage.
|
At delivery.
|
|
Rate of intrapartum caesarean section
Periodo de tiempo: From admission to the Labour suite to delivery, up to 24 hours.
|
To compare between low- and high-requirement parturients the rate of intrapartum caesarean section, expressed as percentage.
|
From admission to the Labour suite to delivery, up to 24 hours.
|
|
Rate of catheter re-siting during labour
Periodo de tiempo: From the placement of the first epidural catheter to delivery, up to 24 hours.
|
To compare between low- and high-requirement parturients the rate of catheter re-siting during labour, expressed as percentage.
|
From the placement of the first epidural catheter to delivery, up to 24 hours.
|
|
Rate of neonatal admission in NICU
Periodo de tiempo: After delivery, up to 1 hour.
|
To compare between low- and high-requirement parturients the rate of neonatal admission in Neonatal Intensive Care Unit (NICU).
|
After delivery, up to 1 hour.
|
|
Mean Apgar Score at 1 minute
Periodo de tiempo: 1 minute after delivery.
|
To compare between low- and high-requirement parturients the neonatal Apgar score at 1 minute, expressed as mean +- DS.
The Apgar score is a 10-point evaluation scoring system used to assess a newborn's health immediately after birth, based on 5 criteria: Appearance, Pulse, Grimace, Activity, and Respiration.
Each category is assigned a score of 0, 1 or 2.
|
1 minute after delivery.
|
|
Mean Apgar Score at 5 minutes
Periodo de tiempo: 5 minutes after delivery.
|
To compare between low- and high-requirement parturients the neonatal Apgar score at 5 minutes, expressed as mean +- DS.
The Apgar score is a 10-point evaluation scoring system used to assess a newborn's health immediately after birth, based on 5 criteria: Appearance, Pulse, Grimace, Activity, and Respiration.
Each category is assigned a score of 0, 1 or 2.
|
5 minutes after delivery.
|
|
Mean Umbilical Cord Arterial pH
Periodo de tiempo: At delivery.
|
To compare between low- and high-requirement parturients the umbilical cord arterial pH, expressed as mean +- DS.
Reference ranges of cord arterial pH is 7.2 - 7.4.
|
At delivery.
|
|
Mean Umbilical Cord Venous pH
Periodo de tiempo: At delivery.
|
To compare between low- and high-requirement parturients the umbilical cord venous pH, expressed as mean +- DS.
Reference ranges of cord venous pH is 7.25 - 7.45.
|
At delivery.
|
|
Mean Umbilical Cord Arterial base excess
Periodo de tiempo: At delivery.
|
To compare between low- and high-requirement parturients the umbilical cord arterial base excess, expressed as mean +- DS.
Reference ranges of cord arterial base excess is -9 to +2.
|
At delivery.
|
|
Mean Umbilical Cord Venous base excess
Periodo de tiempo: At delivery.
|
To compare between low- and high-requirement parturients the umbilical cord venous base excess, expressed as mean +- DS.
Reference ranges of cord venous base excess is -10 to +0.
|
At delivery.
|
|
The rate of maternal hypertensive disorders.
Periodo de tiempo: Throughout pregnancy, up to the first postpartum day.
|
To compare between low- and high-requirement parturients the rate of maternal hypertensive disorders.
|
Throughout pregnancy, up to the first postpartum day.
|
|
The rate of gestational diabetes.
Periodo de tiempo: Throughout pregnancy, up to delivery.
|
To compare between low- and high-requirement parturients the rate of gestational diabetes.
|
Throughout pregnancy, up to delivery.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
13 de junio de 2026
Finalización primaria (Estimado)
30 de septiembre de 2026
Finalización del estudio (Estimado)
31 de octubre de 2026
Fechas de registro del estudio
Enviado por primera vez
8 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
22 de mayo de 2026
Publicado por primera vez (Actual)
29 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
29 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
22 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 27389
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
INDECISO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .